Blog

New NTAA Model Transforms Prognosis for Liver Cancer Patients

The NTAA prognostic model redefines outcomes for BCLC stage B hepatocellular carcinoma (HCC) patients undergoing transarterial chemoembolization (TACE). Analyzing over 2,500 patients, it identified tumor size, number, alpha-fetoprotein levels, and albumin-bilirubin grade as key survival predictors. Dividing patients into low, intermediate, and high-risk groups revealed median survival rates of 68.1, 35.7, and 15.4 months, respectively. The model outperforms traditional criteria, enhancing clinical decision-making and personalizing treatment strategies.

Journal Article by Chen S, Shen L (…) Fan W et 17 al. in Int J Surg

Copyright © 2025 The Author(s). Published by Wolters Kluwer Health, Inc.

read the whole article in Int J Surg

open it in PubMed

EUS-BD Outperform BEA-ERCP in Complex Biliary Obstruction

In a multicenter study, endoscopic ultrasound-guided biliary drainage (EUS-BD) demonstrated superior efficacy to balloon enteroscopy-assisted ERCP (BEA-ERCP) for patients with surgically altered anatomy and unresectable malignant biliary obstruction. EUS-BD achieved a significantly higher technical success rate and shorter procedure times, while maintaining similar clinical success and adverse event rates. BEA-ERCP was identified as an independent predictor of technical failure, particularly in patients with Roux-en-Y reconstruction.

Journal Article by Itonaga M, Takenaka M (…) Kitano M et 16 al. in Dig Endosc

© 2025 Japan Gastroenterological Endoscopy Society.

read the whole article in Dig Endosc

open it in PubMed

Robotic Surgery Beats Laparoscopy in Rectal Cancer Recovery

Robotic colorectal surgery (RCS) significantly accelerates bowel function recovery and reduces major complications compared to laparoscopic colorectal surgery (LCS). In a meta-analysis of 1,731 patients, RCS showed a 0.62-day improvement in bowel function, a 30% decrease in major complications, and a lower conversion rate to open surgery. Although RCS required 22.7 additional minutes of operative time, its advantages in recovery and precision support its expanded use in colorectal cancer treatment.

Review by Mirza W, Dadan S, Khan HM and Yasmin S in J Robot Surg

© 2025. The Author(s), under exclusive licence to Springer-Verlag London Ltd., part of Springer Nature.

read the whole article in J Robot Surg

open it in PubMed

New Benchmarks for Liver Surgery in Colorectal Metastases

Liver resection demonstrates strong oncologic outcomes for colorectal liver metastases (CRLM), with a 90-day mortality rate below 5%. One-year overall survival (OS) rates exceed 85% for most patients, dropping to 78% for those with ten or more metastases. Five-year OS rates range from 28% to 67%, depending on tumor burden. These findings establish critical benchmarks that can guide the evaluation of emerging treatment options like thermal ablation and transplantation.

Journal Article by Viganò L, Risi L (…) Adam R et 12 al. in Ann Surg

Copyright © 2025 Wolters Kluwer Health, Inc. All rights reserved.

read the whole article in Ann Surg

open it in PubMed

ALPPS mortality drops with IDEAL-guided global registry collaboration

Once considered dangerously high-risk, ALPPS has evolved from >15% to <5% 90-day mortality in high-volume centers through a global registry, consensus guidelines, and the IDEAL framework. Since its 2012 debut, the procedure has been tracked in 1,349 cases across 46 countries, enabling evidence-based refinement. This structured approach contrasts with the chaotic adoption of earlier surgical innovations and the current scrutiny of robotic surgery. ALPPS now stands as a model for evaluating disruptive techniques.

Journal Article by Linecker M, Pfister M (…) Clavien PA et 4 al. in Ann Surg

Copyright © 2025 Wolters Kluwer Health, Inc. All rights reserved.

read the whole article in Ann Surg

open it in PubMed

Protease Inhibitors Could Prevent Bleeding After Pancreatic Surgery

Enzymatic interactions from pancreatic juice cause critical vascular damage post-surgery, leading to severe hemorrhage. A study on porcine models reveals that trypsin and chymotrypsin significantly weaken arterial walls when mixed with intestinal fluids. However, administering nafamostat mesylate, a protease inhibitor, effectively mitigates this histopathologic damage. This finding underscores the potential for localized delivery of inhibitors around vascular stumps to reduce life-threatening complications following pancreatoduodenectomy.

Journal Article by Seki Y, Ishizawa T (…) Hasegawa K et 9 al. in BMC Surg

Copyright © 2025 The Author(s). Published by Elsevier Inc. All rights reserved.

read the whole article in BMC Surg

open it in PubMed

Prolonged Hospital Stays Linked to Surgical Patient Risks

Surgical patients in Addis Ababa face median hospital stays of six days, primarily due to comorbidities, infections, and functional impairments. Key predictors include weight loss and dietary changes, all stressing the need for targeted preoperative assessments. A proactive approach could enhance recovery and minimize healthcare costs, vital in resource-limited settings.

Journal Article by Sifer SD, Abdela AA (…) Abere AM et 2 al. in Front Surg

© 2025 Sifer, Abdela, Getachew, Assefa and Abere.

read the whole article in Front Surg

open it in PubMed

Tumor Stage and Histology Crucial for Esophageal Cancer Outcomes

Advanced tumor stage, location, and rare histological types predict poor disease-free survival in surgically treated esophageal cancer patients. Multimodal therapy significantly enhances survival in stage III cases. Notably, squamous cell carcinoma poses a higher locoregional recurrence risk while offering protection against distant metastases. These findings emphasize the need for tailored treatment approaches based on tumor characteristics to improve patient outcomes in a disease known for its aggressive nature.

Journal Article by Fonseca S, Ramos IGS (…) Tustumi F et 2 al. in Arq Bras Cir Dig

read the whole article in Arq Bras Cir Dig

open it in PubMed

Bariatric Surgery Safety Improves, But Progress Stalls

Bariatric surgery has significantly enhanced safety, evidenced by a 40% reduction in 90-day mortality over 15 years and declining severe complications. Among 486,161 procedures, sleeve gastrectomy and gastric bypass remain prevalent. However, improvements have plateaued since 2018, signaling a need for fresh optimization strategies. Notably, postoperative medication use has shifted, with analgesic and antidepressant prescriptions falling sharply while laxatives surged. These trends underline the potential for further advancement in surgical intervention for obesity.

Journal Article by Muller O, Marciniak C (…) Caiazzo R et 10 al. in Ann Surg

Copyright © 2025 Wolters Kluwer Health, Inc. All rights reserved.

read the whole article in Ann Surg

open it in PubMed

Robotic Surgery Proves Safe for Gastric Tumors

A fully robotic, ultrasound-guided technique for organ-sparing resection of gastric gastrointestinal stromal tumors (GISTs) yields impressive results. In a cohort of 46 patients, the procedure demonstrated no intraoperative complications and a postoperative morbidity rate below 5%. All surgeries achieved R0 resection with a median follow-up of 36 months showing a disease-free survival rate of 98%. This method is particularly adept at addressing anatomically challenging lesions while minimizing organ sacrifice.

Journal Article by Guerra F, Matarazzo F (…) Coratti A et 2 al. in J Gastrointest Surg

Copyright © 2025 Society for Surgery of the Alimentary Tract. Published by Elsevier Inc. All rights reserved.

read the whole article in J Gastrointest Surg

open it in PubMed